DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
89.44
+0.28 (0.31%)
Aug 26, 2026, 3:18 PM EDT - Market open
DexCom Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,969 | 4,662 | 4,033 | 3,622 | 2,910 | 2,449 | |
Revenue Growth | 15.54% | 15.60% | 11.34% | 24.49% | 18.84% | 27.08% |
Cost of Revenue | 1,865 | 1,860 | 1,595 | 1,333 | 1,027 | 768 |
Gross Profit | 3,104 | 2,802 | 2,438 | 2,289 | 1,883 | 1,681 |
Selling, General & Admin | 1,361 | 1,291 | 1,286 | 1,185 | 1,008 | 810.5 |
Research & Development | 604 | 599.1 | 552.4 | 505.8 | 484.2 | 604.2 |
Operating Expenses | 1,965 | 1,890 | 1,838 | 1,691 | 1,492 | 1,415 |
Operating Income | 1,139 | 911.8 | 600 | 597.7 | 391.2 | 265.8 |
Interest Expense | -15 | -18.3 | -19 | -20.3 | -18.6 | -18.8 |
Interest & Investment Income | 92.6 | 112.7 | 134.2 | 135 | 23.8 | 1.7 |
Earnings From Equity Investments | -5.4 | - | - | - | - | - |
Other Non Operating Income (Expenses) | 68.7 | 82.2 | -6.2 | -2 | -5.6 | -3.4 |
EBT Excluding Unusual Items | 1,280 | 1,088 | 709 | 710.4 | 390.8 | 245.3 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 11.6 |
Other Unusual Items | - | - | - | - | - | -0.1 |
Pretax Income | 1,280 | 1,088 | 709 | 710.4 | 390.8 | 256.8 |
Income Tax Expense | 280.3 | 252.1 | 132.8 | 168.9 | 49.6 | 39.9 |
Net Income | 999.7 | 836.3 | 576.2 | 541.5 | 341.2 | 216.9 |
Net Income to Common | 999.7 | 836.3 | 576.2 | 541.5 | 341.2 | 216.9 |
Net Income Growth | 74.93% | 45.14% | 6.41% | 58.70% | 57.31% | -60.54% |
Shares Outstanding (Basic) | 386 | 390 | 394 | 386 | 389 | 387 |
Shares Outstanding (Diluted) | 398 | 406 | 413 | 426 | 428 | 429 |
Shares Change | -2.61% | -1.75% | -3.01% | -0.47% | -0.30% | 2.00% |
EPS (Basic) | 2.59 | 2.14 | 1.46 | 1.40 | 0.88 | 0.56 |
EPS (Diluted) | 2.54 | 2.09 | 1.42 | 1.30 | 0.82 | 0.53 |
EPS Growth | 77.35% | 46.73% | 9.35% | 58.06% | 54.74% | -60.09% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,405 | 1,077 | 630.7 | 511.9 | 304.7 | 53.3 |
Free Cash Flow Per Share | 3.54 | 2.66 | 1.53 | 1.20 | 0.71 | 0.12 |
Gross Margin | 62.47% | 60.10% | 60.46% | 63.19% | 64.72% | 68.63% |
Operating Margin | 22.92% | 19.56% | 14.88% | 16.50% | 13.44% | 10.86% |
Profit Margin | 20.12% | 17.94% | 14.29% | 14.95% | 11.73% | 8.86% |
Free Cash Flow Margin | 28.27% | 23.11% | 15.64% | 14.13% | 10.47% | 2.18% |
EBITDA | 1,403 | 1,164 | 817.7 | 783.7 | 547.1 | 367.8 |
EBITDA Margin | 28.24% | 24.96% | 20.28% | 21.63% | 18.80% | 15.02% |
D&A For EBITDA | 264.1 | 251.8 | 217.7 | 186 | 155.9 | 102 |
EBIT | 1,139 | 911.8 | 600 | 597.7 | 391.2 | 265.8 |
EBIT Margin | 22.92% | 19.56% | 14.88% | 16.50% | 13.44% | 10.86% |
Effective Tax Rate | 21.90% | 23.16% | 18.73% | 23.77% | 12.69% | 15.54% |
Advertising Expenses | - | 223.8 | 194.2 | 180.8 | 160.6 | 150.1 |